TRUVELOG MIX 30

This brand name is authorized in Estonia, Croatia, Lithuania, Poland

Active ingredients

The drug TRUVELOG MIX 30 contains one active pharmaceutical ingredient (API):

1 Insulin aspart UNII D933668QVX - INSULIN ASPART

The blood glucose lowering effect of insulin aspart is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. Insulin aspart produces a more rapid onset of action compared to soluble human insulin, together with a lower glucose concentration, as assessed within the first four hours after a meal. Insulin aspart has a shorter duration of action compared to soluble human insulin after subcutaneous injection. Read about Insulin aspart

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRUVELOG MIX 30 Suspension for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10AD05	Insulin aspart	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting
Discover more medicines within A10AD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1881828, 1881839, 1881840, 1881851, 1881862
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1094650, 1094651, 1094652, 1094653, 1094654
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100468140